SKIN vs. BVS, AVNS, CBLL, IRMD, BFLY, SIBN, KIDS, TMCI, SMLR, and CLPT
Should you be buying Beauty Health stock or one of its competitors? The main competitors of Beauty Health include Bioventus (BVS), Avanos Medical (AVNS), CeriBell (CBLL), Iradimed (IRMD), Butterfly Network (BFLY), SI-BONE (SIBN), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Semler Scientific (SMLR), and ClearPoint Neuro (CLPT). These companies are all part of the "medical equipment" industry.
Beauty Health vs.
Beauty Health (NASDAQ:SKIN) and Bioventus (NYSE:BVS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, community ranking, dividends, earnings, profitability and institutional ownership.
93.3% of Beauty Health shares are held by institutional investors. Comparatively, 62.9% of Bioventus shares are held by institutional investors. 41.0% of Beauty Health shares are held by insiders. Comparatively, 32.9% of Bioventus shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
In the previous week, Beauty Health had 16 more articles in the media than Bioventus. MarketBeat recorded 18 mentions for Beauty Health and 2 mentions for Bioventus. Beauty Health's average media sentiment score of 1.04 beat Bioventus' score of -0.06 indicating that Beauty Health is being referred to more favorably in the media.
Beauty Health received 10 more outperform votes than Bioventus when rated by MarketBeat users. However, 62.50% of users gave Bioventus an outperform vote while only 45.98% of users gave Beauty Health an outperform vote.
Bioventus has a net margin of -7.11% compared to Beauty Health's net margin of -8.11%. Bioventus' return on equity of 15.61% beat Beauty Health's return on equity.
Beauty Health has a beta of 0.81, suggesting that its stock price is 19% less volatile than the S&P 500. Comparatively, Bioventus has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500.
Beauty Health has higher earnings, but lower revenue than Bioventus. Bioventus is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.
Beauty Health currently has a consensus target price of $2.55, suggesting a potential upside of 46.55%. Bioventus has a consensus target price of $15.00, suggesting a potential upside of 49.40%. Given Bioventus' stronger consensus rating and higher probable upside, analysts clearly believe Bioventus is more favorable than Beauty Health.
Summary
Bioventus beats Beauty Health on 10 of the 18 factors compared between the two stocks.
Get Beauty Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for SKIN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Beauty Health Competitors List
Related Companies and Tools
This page (NASDAQ:SKIN) was last updated on 1/18/2025 by MarketBeat.com Staff
Free SKIN Stock Alerts